Beth McCoy

Beth McCoy is a Senior Principal Scientist and Group Leader at Pfizer, where they leverage 12 years of experience in analytical development and biologic drug characterization. Holding a Ph.D. in biological chemistry from MIT, Beth has contributed significantly to the successful filing of four BLAs (NIVESTYM, NYVEPRIA, RETACRIT, and HYMPAVZI) throughout their career. Their expertise includes method development and qualification for HPLC, LC-MS, and CE methods, with a track record of delivering high-quality results in the field. Prior roles include postdoctoral research at Geisel School of Medicine, and positions at Hospira and 3M, where they honed their skills in biologic analysis and chemical methodologies.